Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand for costly but highly effective treatments from Novo Nordisk … Read more
The Occidental Petroleum Headquarters is seen on December 11, 2023 in The Woodlands, Texas. Brandon Bell | Getty Images News | Getty Images Berkshire Hathaway has purchased more than 10 million shares of Occidental Petroleum this week worth $588 million, signaling confidence in the oil producer’s pending acquisition of CrownRock. Warren Buffett’s Berkshire now owns … Read more
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial. Those positive results for diabetes patients suffering … Read more
Igor Golovniov | LightRocket | Getty Images Enphase Energy will lay off 10% of its global workforce as part of a restructuring plan, the solar company disclosed in a regulatory filing on Monday. Enphase manufacturers microinverters that convert solar energy into usable electricity. The company’s stock is down 53% this year as high interest rates … Read more
George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed insurance coverage and a handful of unpleasant side effects. … Read more
An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form of skin cancer after three years, according to midstage … Read more
